These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23862622)

  • 1. Reactive oxygen species in cancer biology and anticancer therapy.
    Yang Y; Karakhanova S; Werner J; Bazhin AV
    Curr Med Chem; 2013; 20(30):3677-92. PubMed ID: 23862622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell killing via ROS: to increase or decrease, that is the question.
    Wang J; Yi J
    Cancer Biol Ther; 2008 Dec; 7(12):1875-84. PubMed ID: 18981733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting antioxidants for cancer therapy.
    Glasauer A; Chandel NS
    Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species in cancer: Current findings and future directions.
    Nakamura H; Takada K
    Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression.
    Ismail T; Kim Y; Lee H; Lee DS; Lee HS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.
    Yang W; Zou L; Huang C; Lei Y
    Drug Dev Res; 2014 Aug; 75(5):331-41. PubMed ID: 25160073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species and cancer paradox: To promote or to suppress?
    Galadari S; Rahman A; Pallichankandy S; Thayyullathil F
    Free Radic Biol Med; 2017 Mar; 104():144-164. PubMed ID: 28088622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
    Smith DG; Magwere T; Burchill SA
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cellular reactive oxygen species in cancer chemotherapy.
    Yang H; Villani RM; Wang H; Simpson MJ; Roberts MS; Tang M; Liang X
    J Exp Clin Cancer Res; 2018 Nov; 37(1):266. PubMed ID: 30382874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of reactive oxygen species: an emerging approach for cancer therapy.
    Zou Z; Chang H; Li H; Wang S
    Apoptosis; 2017 Nov; 22(11):1321-1335. PubMed ID: 28936716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS signalling in the biology of cancer.
    Moloney JN; Cotter TG
    Semin Cell Dev Biol; 2018 Aug; 80():50-64. PubMed ID: 28587975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison.
    Chong SJF; Lai JXH; Eu JQ; Bellot GL; Pervaiz S
    Antioxid Redox Signal; 2018 Dec; 29(16):1553-1588. PubMed ID: 29186971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental therapeutics: targeting the redox Achilles heel of cancer.
    Cabello CM; Bair WB; Wondrak GT
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding of ROS-Inducing Strategy in Anticancer Therapy.
    Kim SJ; Kim HS; Seo YR
    Oxid Med Cell Longev; 2019; 2019():5381692. PubMed ID: 31929855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Development of ROS-Modulating Agents as Novel Antitumor Therapy.
    Wang N; Wu Y; Bian J; Qian X; Lin H; Sun H; You Q; Zhang X
    Curr Cancer Drug Targets; 2017; 17(2):122-136. PubMed ID: 26881931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation.
    Tian H; Gao Z; Wang G; Li H; Zheng J
    Tumour Biol; 2016 Jan; 37(1):141-50. PubMed ID: 26566628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of redox signal transduction pathways in the treatment of cancer.
    Greenberger JS; Kagan VE; Pearce L; Boriseniao G; Tyurina Y; Epperly MW
    Antioxid Redox Signal; 2001 Jun; 3(3):347-59. PubMed ID: 11491649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.